Back

Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network

24 May 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Beta blockers Beta blockers HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Associate Professor David Peter Kao

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Coiro (Perugia, IT)
Abstract
Presentation thumbnail
Doctor C. Di Nora (Udine, IT)
Presentation thumbnail
Doctor D. Masarone (Naples, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Beta blockers

The Event

Event poster

HEART FAILURE 2016

24 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
High dosages of betablockers are related to left ventricular reverse remodelling in patients with recent-onset non-ischaemic dilated cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
NRF2/beta3-adrenoreceptor signaling drives a sustained antioxidant and metabolic rewiring through the pentose-phosphate pathway to alleviate cardiac stress
1 September 2025
thumbnail
Congress Presentation
Age characteristics of changes in the adrenergic reactivity of erythrocytes at heart failure in rats
29 June 2021
thumbnail
Congress Presentation
The impact of adrenoceptor-1 gene polymorphism on structural and functional features in patients with hypertrophic cardiomyopathy
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources